The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation - PubMed

Affiliations

• PMID: 10739663
• DOI: 10.1006/excr.2000.4820

The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation

J Lemonnier et al. Exp Cell Res. 2000.

Abstract

We recently showed that the Apert Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation causes premature osteoblast differentiation and increased subperiosteal calvaria bone matrix formation. To gain further insight into the cellular mechanisms involved in these effects, we examined the effects of the mutation on the expression of FGFRs in relation to cell proliferation and differentiation markers in vivo and in vitro, and we analyzed the underlying signaling pathways in mutant cells. Immunohistochemical analysis of the Apert calvaria suture showed that the Ser252Trp FGFR-2 mutation increased type 1 collagen, osteocalcin, and osteopontin expression in preosteoblasts compared to normal, whereas cell growth was not affected. The premature osteoblast differentiation induced by the mutation was associated with lower than normal FGFR-2 immunolabeling, whereas FGFR-1 and FGFR-3 levels were not decreased. Immunocytochemical analysis in osteoblasts isolated from Apert coronal suture showed that the Ser252Trp mutation induced constitutive downregulation of FGFR-2 in mutant cells. Western blot analysis of FGFRs in immortalized mutant osteoblastic cells confirmed that the mutation induced FGFR-2 downregulation. FGFR-2 mRNA levels were not altered in mutant cells, indicating that FGFR-2 downregulation resulted from receptor internalization rather than from changes in receptor mRNA. The signaling pathway involved in FGFR-2 downregulation was studied using specific inhibitors of FGF signaling molecules. The selective PKC inhibitor calphostin C markedly reduced FGFR-2 protein levels in mutant cells, in contrast to the p38 MAP kinase inhibitor SB 203580 or the Erk 1,2 MAP kinase inhibitor PD-98059, showing that PKC is involved in FGFR-2 regulation, but not in FGFR-2 downregulation in mutant cells. The results indicate that the premature osteoblast differentiation induced by the FGFR-2 Ser252Trp mutation is associated with a PKC-independent downregulation of FGFR-2 in human calvaria cells.

Similar articles

• Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis.

  Lemonnier J, Haÿ E, Delannoy P, Lomri A, Modrowski D, Caverzasio J, Marie PJ. Lemonnier J, et al. J Bone Miner Res. 2001 May;16(5):832-45. doi: 10.1359/jbmr.2001.16.5.832. J Bone Miner Res. 2001. PMID: 11341328

• Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome.

  Lomri A, Lemonnier J, Hott M, de Parseval N, Lajeunie E, Munnich A, Renier D, Marie PJ. Lomri A, et al. J Clin Invest. 1998 Mar 15;101(6):1310-7. J Clin Invest. 1998. PMID: 9502772 Free PMC article.

• Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling.

  Marie PJ, Debiais F, Haÿ E. Marie PJ, et al. Histol Histopathol. 2002;17(3):877-85. doi: 10.14670/HH-17.877. Histol Histopathol. 2002. PMID: 12168799 Review.

• FGF/FGFR signaling in bone formation: progress and perspectives.

  Marie PJ, Miraoui H, Sévère N. Marie PJ, et al. Growth Factors. 2012 Apr;30(2):117-23. doi: 10.3109/08977194.2012.656761. Epub 2012 Feb 1. Growth Factors. 2012. PMID: 22292523 Review.

Cited by

• Molecular analysis of coronal perisutural tissues in a craniosynostotic rabbit model using polymerase chain reaction suppression subtractive hybridization.

  Cray JJ Jr, Gallo PH, Durham EL, Losee JE, Mooney MP, Kathju S, Cooper GM. Cray JJ Jr, et al. Plast Reconstr Surg. 2011 Jul;128(1):95-103. doi: 10.1097/PRS.0b013e31821740e8. Plast Reconstr Surg. 2011. PMID: 21701325 Free PMC article.

• Signaling networks that control the lineage commitment and differentiation of bone cells.

  Soltanoff CS, Yang S, Chen W, Li YP. Soltanoff CS, et al. Crit Rev Eukaryot Gene Expr. 2009;19(1):1-46. doi: 10.1615/critreveukargeneexpr.v19.i1.10. Crit Rev Eukaryot Gene Expr. 2009. PMID: 19191755 Free PMC article. Review.

• FGF9 on the move.

  Spicer D. Spicer D. Nat Genet. 2009 Mar;41(3):272-3. doi: 10.1038/ng0309-272. Nat Genet. 2009. PMID: 19240749 No abstract available.

• Signaling and transcriptional regulation in osteoblast commitment and differentiation.

  Huang W, Yang S, Shao J, Li YP. Huang W, et al. Front Biosci. 2007 May 1;12:3068-92. doi: 10.2741/2296. Front Biosci. 2007. PMID: 17485283 Free PMC article. Review.

• Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology.

  Holmes G, Rothschild G, Roy UB, Deng CX, Mansukhani A, Basilico C. Holmes G, et al. Dev Biol. 2009 Apr 15;328(2):273-84. doi: 10.1016/j.ydbio.2009.01.026. Epub 2009 Jan 29. Dev Biol. 2009. PMID: 19389359 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal